CClinicalTrials.gg
CompletedNCT07257783BBE PSE VO2maxUpdated Dec 2, 2025

Effect of Buteyko Breathing Exercise Combined With Postural Stability Exercises on Maximal Oxygen Consumption in Young Adult Smokers

An interventional study of Buteyko breathing exercise combined with postural stability exercises in Smoking ( Cigarette), sponsored by Yasmeen Alaa Abd El-Hamied Ahmeed. Completed at 1 site in Egypt. Open to male participants aged 18 Years to 30 Years. Per ClinicalTrials.gov, last updated 2025-12-02.

Sponsored by Yasmeen Alaa Abd El-Hamied Ahmeed · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 3 months after the study started (first participant enrolled Jul 2024, registered Nov 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
46
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
Male
01

Study summary

Background: Smoking is one of the most significant risk factors for respiratory diseases, affecting both lung function and overall respiratory health. The harmful chemicals in tobacco smoke, contribute to airway inflammation, oxidative stress, and structural lung damage.

Purpose: The purpose of this study was to investigate effect of Buteyko breathing exercise combined with postural stability exercises on maximal oxygen consumption, pulmonary functions, oxygen saturation, functional capacity, and perceived exertion in young adult smokers. Subjects and procedures: Forty male smokers were recruit-ed from Nahda university. Their age ranged between 18-30 years. They were randomly assigned into 2 groups equal in number. Study Group: They participated in 6 weeks training with Buteyko breathing exercise combined with postural stability exercises (3 sessions per week) Control group: They weren't exposed to any intervention. Both groups were assessed by using pulse oximeter to measure oxy-gen saturation, Spirostilk to measure pulmonary functions, Borg scale to measure perceived exertion and six-minute walk test to measure functional capacity and maximal oxygen consumption.

02

Conditions studied

  • Smoking ( Cigarette)

Browse trials for

Keywords

  • Buteyko breathing exercise
  • Postural stability exercises
  • maximal oxygen consumption
  • young adult smokers
03

In context

Cigarette Smoking

114 studies on the registry are indexed under Cigarette Smoking; 59 are open to participants now.

This study's enrollment of 46 is below the median of 100 across 101 interventional studies indexed under Cigarette Smoking.

Browse Cigarette Smoking studies →

Lead sponsor

This is the only study on the registry with Yasmeen Alaa Abd El-Hamied Ahmeed as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
Male
Accepts healthy volunteers
No

Inclusion criteria

  • Cigarette Smokers.
  • Smoking period from 3 to 7 years
  • They were medically stable.
  • Age between 18 to 30 years.
  • Male gender only was allowed to participate.
  • They had the ability to perform exercises.
  • Body mass index ranges from 21 to 25.

Exclusion criteria

exclusion criteria

  • Smokers diagnosed with any chronic disease or orthopedic problems.
  • Mental disorders.
  • Current intervention for cancer or active infection
  • Obese their BMI above 26 and athlete people
  • People who participated in any activity such as walking for long periods and swimming
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
46 participants (actual)

Study arms

  • No intervention
    control group

    smokers didn't receive any intervention just measurement at the start of the study and at the end of the study

  • Experimental
    study group

    Buteyko breathing exercise combined with postural stability exercises

    Other: Buteyko breathing exercise combined with postural stability exercises

Interventions

  • OtherButeyko breathing exercise combined with postural stability exercises

    BBE: The therapist instructs the patient to sit comfortably, breathing naturally through the nose. They should hold their breath until the need to inhale arises, then exhale through the nasal passage. The patient maintains a straight back with feet shoulder-width apart, eyes closed, breathing calmly. After 20-30 seconds, they repeat the exercises for 3 minutes, followed by another pause and repetition. This is done for another 3 minutes, ending with a 2-minute rest before the next session. Duration: 15 minutes. PSE :Warming up phase: shoulder circles and twist torso during walking for 5 minutes. Training phase include 10-15 reps per set, 2-4 sets per exercise,30-60 seconds rest period between sets. Cooling down phase includes hold each stretch for 15-30 seconds, 2-4 reps per per side and rest for 15-30 seconds between reps. Bridging Side-lying leg raise Wall push-ups Lateral trunk flexion Chin tuck Stretch pectoralis major muscle,upper trapezius \& SCM All these for 3/week for 6 weeks

06

What researchers measure

Primary outcomes

  1. maximal oxygen consumption

    it is the highest rate at which the body can take in, transport, and utilize oxygen during intense exercise. It is considered a key indicator of cardiovascular fitness and endurance performance. Measured in: Milliliters of oxygen per kilogram of body weight per minute (ml/kg/min). it was calculated by estimated method from six minute walk test by this equation 12.701 + (0.06 × 6-minute walk distance m) - (0.732 × body mass indexkg/m2)

    Time frame: From enrollment to the end of treatment at 6 weeks

Secondary outcomes

  1. oxygen saturation

    it refers to the percentage of hemoglobin molecules saturated with oxygen.Pulse oximetry is a simple, non-invasive, widely available medical tool that measures SpO2 through a device attached to a finger, a toe or an ear lobe.

    Time frame: From enrollment to the end of treatment at 6 weeks

  2. forced viral capacity

    Spirometry was used to forced vital capacity (FVC)

    Time frame: From enrollment to the end of treatment at 6 weeks

  3. perceived rate of exertion

    Measurement of PRE by Modified Borg scale It was used to rate how hard a person feels they are working from 0 to10 0 = No exertion at all \& 10 = Maximal exertion

    Time frame: From enrollment to the end of treatment at 6 weeks

  4. Functional capacity

    It was used to assess the cardiopulmonary fitness of the individuals. it is measured from 6-MWT

    Time frame: From enrollment to the end of treatment at 6 weeks

  5. the ratio of forced expiratory volume in 1 Second to forced vital capacity

    Spirometry: was used to assess the ratio of forced expiratory volume in 1 Second (FEV₁) to forced vital capacity (FEV₁ /FVC)

    Time frame: From enrollment to the end of treatment at 6 week

  6. forced expiratory volume in 1 Second

    Spirometry was used to assess forced expiratory volume in 1 Second (FEV₁)

    Time frame: From enrollment to the end of treatment at 6 week

  7. Maximum voluntary ventilation

    Spirometry was used to assess maximum voluntary ventilation (MVV)

    Time frame: From enrollment to the end of treatment at 6 week

07

Study locations

1 site
  • faculty of physical therapy Nahda University
    Banī Suwayf, Egypt
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 2, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07257783
Lead sponsor
Yasmeen Alaa Abd El-Hamied Ahmeed
Responsible party
Yasmeen Alaa Abd El-Hamied Ahmeed (Teaching Assistant at Department of Physical Therapy for Internal Medicine & Geriatrics Faculty of Physical Therapy, Nahda University, Beni Suef, Egypt, October 6 University) — Sponsor-investigator
First posted
Dec 2, 2025
Start date
Jul 20, 2024
Primary completion
Dec 1, 2024
Completion
Jan 10, 2025
Last update
Dec 2, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion